The average clinical trial screen failure rate is 60%. That means for every 10 patients referred to your site, 6 fail screening, after coordinators have already invested time in contact, consent, and medical record collection.
That's your biggest hidden cost in patient recruitment.
AI Verdict: Likely Eligible, schedule pre-screening call
Turnaround: 24 hours from record receipt
What Hekma's AI Does
Aggregated via FHIR, every provider the patient has seen, unified into one record
Every inclusion and exclusion criterion from your trial protocol, automatically applied
Likely Eligible / Borderline / Likely Ineligible, with evidence for each determination
Flags patients that need one specific data point to confirm vs. patients that clearly do not qualify
Not the full record. Not a pile of PDFs. A structured verdict with the evidence behind it.
AI summaries generated within 24 hours of record receipt. Trained specifically on clinical trial I/E logic.
Before / After
| Without Hekma | With Hekma | Outcome |
|---|---|---|
| Manual record review, 3–6 weeks per cohort | AI summarisation, 24-hour turnaround per batch | Cut pre-screening time by 95% |
| 60% screen failure, coordinators wasted on ineligible patients | Only likely-eligible patients reach your sites | Screen failure: 60% → under 20% |
| Pile of PDFs from 5 different providers | One structured page per patient with criterion-level evidence | First call is a confirmation, not an investigation |
Compliance & Standards
AI summarisation pre-screens every candidate so your coordinators only talk to likely-eligible patients.